Peptide therapy TikTok claims: what the science actually says

What did @landotalkspeps actually say?

The creator pinned 300 micrograms of Melanotan II (MT2), then immediately entered a tanning bed, filming before-and-after footage to demonstrate what they called "the quickest method to get tan." They acknowledged the peptide "hasn't even kicked in fully" post-session but predicted being "a lot more tan" by morning. This is a real-time protocol demo, not a theoretical claim, and that specificity is worth examining closely.

The core claim is that combining MT2 with UV exposure accelerates visible tanning faster than either method alone. There's also an implicit claim baked in: that 300 micrograms is an effective dose for this kind of acute response. We'll get to why that second part is where things get more complicated.

Does the science back this up?

Partially, yes. MT2 (melanotan II) is a synthetic analogue of alpha-melanocyte-stimulating hormone (alpha-MSH). It binds melanocortin receptors, particularly MC1R, triggering melanogenesis, the process of melanin production in skin cells. The science here is not contested. Hadley and Dorr (2006, Peptides) documented this mechanism clearly, and subsequent work confirmed that MT2 increases eumelanin synthesis, the pigment responsible for darker skin tones.

The combination with UV light is where it gets interesting. Melanin production requires a stimulus, and UV radiation is a natural one. Using MT2 alongside UV exposure is not chemically inert. A study by Dorr et al. (1996, Journal of Investigative Dermatology) found that MT2 combined with low-dose UV produced significantly greater tanning responses than UV alone. So the creator's strategy has a real mechanistic basis. That said, "kicking in" within hours is an oversimplification of how melanogenesis actually unfolds at the cellular level.

What did they get wrong (or right)?

Credit where it's due: the general claim that MT2 plus UV speeds tanning is supported by the pharmacology. Dorr's 1996 data showed measurable pigmentation increases within days when MT2 and UV were combined, which loosely supports the overnight timeline the creator references.

What they got wrong, or at least glossed over, is the risk profile of this combo. MT2 is not approved by the FDA. It carries a documented side effect profile including nausea, spontaneous erections, flushing, and, more seriously, the potential to stimulate existing atypical moles or nevi. Langan et al. (2010, British Journal of Dermatology) raised concerns about MT2's activation of MC1R on melanocytes in pre-existing dysplastic nevi, which is not a trivial cosmetic concern. Combining an unlicensed melanocortin agonist with UV exposure, a known carcinogen, is a stack the video treats as a casual tip. That framing is the real problem here.

The creator also offers no safety context whatsoever. No mention of skin checks, no mention of prior medical history, no acknowledgment that this compound is not regulated or quality-tested in commercial supply chains.

What should you actually know?

MT2 is real, the mechanism is real, and the tanning effect is real. But "quickest method" framing strips out context that actually matters for anyone considering this.

First, MT2 sold outside of a regulated clinical setting has no guaranteed purity or concentration. You are not necessarily injecting what the label says. Second, using UV beds alongside a melanocortin agonist compounds both the desired and undesired effects of UV, including DNA damage to skin cells. The World Health Organization classifies UV tanning devices as Group 1 carcinogens. Adding a compound that ramps up melanocyte activity does not cancel that risk.

Third, there is a practical concern around dosing variability. The 300 microgram figure the creator uses is specific, but individual responses to MT2 vary considerably depending on skin type, receptor sensitivity, and body composition. What produces a mild flush in one person can cause significant nausea or cardiovascular symptoms in another. Pearce et al. (2002, Peptides) noted that adverse events in MT2 trials were dose-dependent and not uniformly predictable.

If you are interested in MT2 for medical reasons, that conversation belongs with a licensed provider who can review your skin history, mole burden, and cardiovascular risk, not a TikTok tutorial.